ENOX2 and lip and oral cavity carcinoma: The three heteroarene-fused anthraquinones studied herein target and downregulate tNOX to reduce SIRT1 deacetylase activity and increase Ku70 acetylation, which triggers c-Flip degradation and induces apoptosis in oral cancer cells.